Naoki Katase1, Kenichi Nagano2, Shuichi Fujita2. 1. Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, Nagasaki, 852-8588, Japan. Electronic address: katase@nagasaki-u.ac.jp. 2. Department of Oral Pathology, Institute of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, Nagasaki, 852-8588, Japan.
Abstract
BACKGROUND: Cancer arises from cumulative genetic or epigenetic aberrations, or the destabilization of central signaling pathways that regulate cell proliferation, differentiation, cell cycle, gene transcription, migration, angiogenesis and apoptosis. Investigating the cancer-specific genetic background is important to get deeper apprehension of cancer biology. In this review, we aimed to identify head and neck squamous cell carcinoma (HNSCC)-specific genes and identified DKK3 gene as a candidate. HIGHLIGHT: DKK3 belongs to the DKK family (DKK1, DKK2, DKK3 and DKK4), which codes for an evolutionally conserved secreted glycoprotein that is characterized by two distinct cysteine rich domains and functions as an antagonist of the oncogenic Wnt signaling pathway. It has been reported that DKK3 expression is decreased in many kinds of cancers, and it is thus thought to be a tumor suppressor gene. However, our investigations have demonstrated unique expression and function of DKK3 in HNSCC. DKK3 protein expression is predominantly positive in HNSCC, and DKK3-positive patients show significantly shorter disease-free survival rates, whereas DKK3-negative cases do not show metastasis. Molecular biological analyses demonstrated that DKK3 over expression significantly increased HNSCC cell proliferation, migration, and invasion via increased phosphorylation of AKT. Moreover, DKK3 knockdown in HNSCC cells significantly decreased these malignant potentials through decreased AKT phosphorylation. CONCLUSION: Our previously published data, alongside those from other reports, indicate that DKK3 may have an additional oncogenic function other than tumor suppression.
BACKGROUND: Cancer arises from cumulative genetic or epigenetic aberrations, or the destabilization of central signaling pathways that regulate cell proliferation, differentiation, cell cycle, gene transcription, migration, angiogenesis and apoptosis. Investigating the cancer-specific genetic background is important to get deeper apprehension of cancer biology. In this review, we aimed to identify head and neck squamous cell carcinoma (HNSCC)-specific genes and identified DKK3 gene as a candidate. HIGHLIGHT: DKK3 belongs to the DKK family (DKK1, DKK2, DKK3 and DKK4), which codes for an evolutionally conserved secreted glycoprotein that is characterized by two distinct cysteine rich domains and functions as an antagonist of the oncogenic Wnt signaling pathway. It has been reported that DKK3 expression is decreased in many kinds of cancers, and it is thus thought to be a tumor suppressor gene. However, our investigations have demonstrated unique expression and function of DKK3 in HNSCC. DKK3 protein expression is predominantly positive in HNSCC, and DKK3-positive patients show significantly shorter disease-free survival rates, whereas DKK3-negative cases do not show metastasis. Molecular biological analyses demonstrated that DKK3 over expression significantly increased HNSCC cell proliferation, migration, and invasion via increased phosphorylation of AKT. Moreover, DKK3 knockdown in HNSCC cells significantly decreased these malignant potentials through decreased AKT phosphorylation. CONCLUSION: Our previously published data, alongside those from other reports, indicate that DKK3 may have an additional oncogenic function other than tumor suppression.
Authors: Myung-Hoon Han; Kyueng-Whan Min; Yung-Kyun Noh; Jae Min Kim; Jin Hwan Cheong; Je Il Ryu; Yu Deok Won; Seong-Ho Koh; Jae Kyung Myung; Ji Young Park; Mi Jung Kwon Journal: Cancer Immunol Immunother Date: 2022-05-23 Impact factor: 6.630
Authors: Myung-Hoon Han; Kyueng-Whan Min; Yung-Kyun Noh; Jae Min Kim; Jin Hwan Cheong; Je Il Ryu; Yu Deok Won; Seong-Ho Koh; Young Mi Park Journal: Front Oncol Date: 2022-08-10 Impact factor: 5.738
Authors: Frank Arnold; Pallavi U Mahaddalkar; Johann M Kraus; Xiaowei Zhong; Wendy Bergmann; Dharini Srinivasan; Johann Gout; Elodie Roger; Alica K Beutel; Eugen Zizer; Umesh Tharehalli; Nora Daiss; Ronan Russell; Lukas Perkhofer; Rupert Oellinger; Qiong Lin; Ninel Azoitei; Frank-Ulrich Weiss; Markus M Lerch; Stefan Liebau; Sarah-Fee Katz; André Lechel; Roland Rad; Thomas Seufferlein; Hans A Kestler; Michael Ott; Amar Deep Sharma; Patrick C Hermann; Alexander Kleger Journal: Adv Sci (Weinh) Date: 2021-05-13 Impact factor: 16.806